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Background: Improvement in quality of life (QOL) has become a focus for the management 
of incurable chronic diseases, including chronic obstructive pulmonary disease (COPD). This 
study investigates factors influencing the QOL of patients with COPD in India.
Methods: Seventy-three consecutive COPD patients visiting an outpatient pulmonary clinic 
underwent health-related QOL (HRQOL) assessment using the World Health Organization’s 
QOL abbreviated questionnaire and St George’s Respiratory Questionnaire (SGRQ).   Symptom 
severity and grade of dyspnea were estimated by the Chronic Lung Disease Severity Index 
(CLD) and Medical Research Council assessments, and patient demographic data were   collected. 
Spirometry and 6-minute walk tests were performed to assess lung function and functional 
status.
Results: Patients with COPD showed significantly reduced HRQOL when measured by the 
World Health Organization’s QOL abbreviated questionnaire and the SGRQ. CLD estimate 
for severity of lung disease (P , 0.001), Medical Research Council assessment for dyspnea 
(P , 0.01), and duration of illness (P , 0.05) showed close correlation with HRQOL.   Worsening 
forced expiratory volume in 1 second and 6-minute walk test results closely correlated with poorer 
HRQOL (P , 0.01). No association between QOL and age, quantum of smoking,   education, 
comorbid illnesses, or occupational exposure was found.
Conclusion: This study showed that Indian patients with COPD had reduced HRQOL.   Longer 
disease duration, patient perception of disease severity, and worsening dyspnea impacted 
negatively on HRQOL.
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Introduction
The Global Initiative for Chronic Obstructive Lung Diseases (GOLD) 2001 defined 
chronic obstructive pulmonary disease (COPD) as a disease state characterized by 
chronic airflow obstruction that is not fully reversible. This airflow limitation is   usually 
both progressive and associated with an abnormal inflammatory response of the lungs to 
noxious particles or gases.1 COPD progressively reduces breathing capacity and impairs 
patients’ ability to carry out activities of daily living, thereby adversely affecting 
health-related quality of life (HRQOL). A World Health Organization (WHO)/World 
Bank study estimated the prevalence of COPD per 1000 population in India as 4.38 in 
males and 3.44 in females.2 With the increasing prevalence of smoking in developing 
countries, it is projected that COPD-related mortality and morbidity will dramatically 
impact Asian and African countries.3 COPD is an irreversible and progressive   disease, 
and hence medical and surgical care results in very little improvement of lung function 
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or survival of these individuals, aside from the benefits 
seen with use of long-term oxygen treatment. Patients with 
COPD experience reduced HRQOL. Some factors such as 
depression, poor mobility, dyspnea, and inadequate social 
support adversely affect HRQOL, and these factors may 
be more amenable to treatment than treating only lung 
function impairment. Patient-focused HRQOL studies will 
provide the health care personnel with specific information 
regarding the problems that these patients experience and 
will thereby enable them to develop interventions directed 
toward improving their care.
There is a paucity of published literature regarding factors 
affecting the QOL of COPD patients in India. The present 
study aimed at determining the relationship between QOL 
and selected demographic and physiologic variables and 
symptom severity scores of patients with COPD.
Materials and methods
Study design
Patients visiting their pulmonologist for initial consultation 
for dyspnea or follow-up outpatient visits for COPD were 
invited to participate in this study. Basic demographic 
data and the generic WHOQOL abbreviated questionnaire 
(WHOQOL-BREF)4 were completed on the first visit, and 
1 week later the disease-specific St George’s Respiratory 
Questionnaire (SGRQ)5 clinical and physiologic data were 
gathered. This prospective study was approved by the 
Christian Medical College, Vellore, South India, and the 
hospital’s institutional review board.
Patient population
Seventy-three consecutive COPD patients were enrolled over 
a 2-month period in this study, which was performed at the 
pulmonary medicine outpatient clinic at Christian Medical 
College and hospital, a 2100-bed tertiary referral hospital 
and medical school in Tamilnadu, South India. Inclusion 
criteria for patient participation consisted of age over 40 
years and irreversible airway obstruction on spirometry. 
Fifteen subjects were ineligible due to their inability to per-
form a 6-minute walk (nine), refusal to participate (three), 
additional coexisting lung disease (two), and flare-up of 
COPD (one).
Testing methods
Spirometry was performed using a pulmonary function 
testing system (MasterScreen PFT®; Jaeger, Höchberg, 
  Germany). Pre- and postbronchodilator (salbutamol 
400 mcg) maneuvers were done by qualified respiratory 
therapists following American Thoracic Society standards.6 
COPD was documented by airflow obstruction showing 
forced expiratory volume in 1 second (FEV1)/forced vital 
capacity (FVC) ,70% and less than 200 cc increase in 
FEV1 post b  ronchodilator. Disease severity was classified 
according to GOLD criteria. A 6-minute walk test was 
  performed in a 30-meter corridor.
HRQOL was measured using two questionnaires: 
the generic WHOQOL-BREF4 and the disease-specific 
SGRQ.5
The WHOQOL-BREF has 26 questions, of which the 
first two yield information about the individual’s   overall 
p  erception of QOL and overall perception of health. 
The remaining questions assess QOL in four domains: 
  physical, psychological, social relationships, and environ-
mental. It is a positively scored questionnaire, with the scores 
of the negatively worded questions being reversed for total 
score calculation. Higher scores indicate better QOL. The 
final scores were interpreted as follows: $75% = good QOL, 
50%–74% = fair QOL, and ,50% = poor QOL.
The SGRQ is a standardized questionnaire used to assess 
the effect of respiratory diseases on QOL. It is divided into three 
sections: “symptoms” deals with the frequency and severity of 
respiratory manifestations, “activity” relates to activities that 
cause or are limited by breathlessness, and “impacts” covers 
the aspects of social function and psychosocial disturbances 
that result from respiratory diseases.
Scores were expressed as percentage of overall 
impairment, where 100 represents worst possible health 
and 0 indicates best possible health status. Higher status on 
SGRQ indicates poorer QOL.
The Chronic Lung Disease Severity Index (CLD)7 was 
used to quantify respiratory symptoms. This short six-item 
questionnaire evaluated dyspnea, wheezing, and productive 
cough. Raw scores were added and transformed to a scale 
of 0 (normal) to 100 (most severe). Dyspnea was assessed 
by the Medical Research Council (MRC) five-point scale 
for breathlessness.
The demographic variables, such as education, occupation, 
and smoking status, were analyzed with the mean QOL scores 
using the Kruskal-Wallis test, and the relationship between 
HRQOL scores and continuous variables were assessed using 
Spearman’s correlation coefficient (r). A P-value of ,0.05 
was considered statistically significant.
Results
Patient demographic results show a mean age of 62 years. 
Fifty-four were male (93%), 56 were married (97%), 
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49 completed some formal schooling (86%), and 48 were 
current or ex-smokers (83%), with an average 32 pack-year 
smoking history (Table 1).
Clinical characteristics showed a mean duration of illness 
of 6 years; a mean CLD index of 55, indicating moderately 
severe disease; a dyspnea severity score of 2.6, indicating 
moderately severe dyspnea; and comorbid illness found in 
65% (Table 2).
Spirometry showed that one subject was GOLD (2001) 
Stage I, 46 were Stage II, and eleven were Stage III. Mean 
6-minute walk was 359 meters (Table 3).
WHOQOL-BREF results showed that 14 patients rated 
QOL to be good, 31 fair, and 13 poor (Tables 4 and 5). 
When separate domains were analyzed, the worse the overall 
QOL, the worse the physical symptoms, whereas trends with 
  psychological and social scores suggested that these remained 
relatively high despite advanced disease. The SGRQ scores 
likewise showed significant impairment in all three domain 
measures, symptoms, activity, and impacts, when compared 
with reference values5 (Table 4).
No association was identified between QOL and 
the demographic variables age, education, occupation 
  exposure, smoking status, or pack-years of tobacco smoked 
(Table 6).
Duration of illness showed a significant correlation 
with the WHOQOL-BREF questionnaire (P , 0.05), 
indicating that as duration of illness increased, the QOL 
Table 1 Demographic characteristics of 58 subjects with chronic 
obstructive pulmonary disease
Characteristic Value
Mean age ± standard deviation (years) 62.4 ± 7.83
Sex
Male 54 (93%)
Female 4 (7%)
Marital status
Unmarried 0
Married 56 (97%)
widowed/widower 2 (3%)
Divorced 0
Education
Illiterate 9 (15%)
Primary 7 (12%)
Secondary 28 (48%)
Graduate and above 14 (24%)
Smoking status
Never smoked 10 (17%)
Quit smoking 39 (67%)
Current smoker 9 (16%)
Mean pack-years of tobacco smoked  
(± standard deviation)
32 ± 34.55
Table 2 Clinical characteristics of the 58 study subjects
Clinical variables Values
Mean duration of illness ± standard deviation (years) 6.07 ± 6.06
Mean CLD Severity Index 55.03 ± 14.19
Comorbid condition (number of patients)
Nil 20 (34%)
Gastric disease 12 (21%)
Hypertension 11 (19%)
Diabetes mellitus 10 (17%)
Cataract 9 (16%)
Heart disease 9 (16%)
Prostatic disease 4 (7%)
Osteoarthritis/rheumatoid arthritis 4 (7%)
Miscellaneous 6 (10%)
Number of patients with comorbid conditions
0 20 (34%)
1 17 (29%)
2 14 (24%)
$3 7 (12%)
Mean dyspnea score (MRC grade ) ±standard deviation 2.6 ± 1.35
Long-term oxygen therapy
Yes 0%
No 58% (100%)
Abbreviations: CLD, Chronic Lung Disease Severity Index; MRC, Medical Research 
Council.
Table  3  Spirometry  and  6-minute  walk  results  of  the  study 
subjects
Physiological variables Values
Disease severity (%)
Stage I (FEV1 $ 80% of the predicted value) 1 (2%)
Stage IIA (FEV1 50%–79% of the predicted value) 25 (43%)
Stage IIB (FEV1 30%–49% of the predicted value) 21 (36%)
Stage III (FEV1 , 30% of the predicted value) 11 (19%)
Mean FEV1% predicted ± standard deviation 47.6 ± 18.38
Mean 6-minute distance walked ± standard deviation 
(meters)
359.2 ± 92.52
Abbreviation: FEV1, forced expiratory volume in 1 second.
Table 4 Mean health-related quality of life scores
Quality of life Mean Standard  
deviation
Range
WHOQOL-BREF
Physical domain 51.60 23.47 6–94
Social domain 62.03 27.26 6–100
Psychological domain 71.78 19.56 25–100
Environmental domain 64.29 14.23 30–94
Total 62.50 15.63 28–94
SGRQ
Symptoms 41.64 20.99 0–93
Activity 62.57 24.61 0–100
Impacts 39.21 23.52 0–92
Total 46.69 21.61 0–88
Abbreviations: SGRQ, St George’s Respiratory Questionnaire; wHOQOL-BREF, 
world Health Organization’s quality of life abbreviated questionnaire.
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Table 6 Correlation of SGRQ and wHOQOL-BREF scores with demographic variables
Variable SGRQ WHOQOL-BREF
Symptom Activity Impacts Total
Agea, r-value 0.079 0.175 0.035 0.056 -0.135
Pack-years of tobacco smokeda, r-value 0.16 0.19 0.19 0.18 0.03
Educationb, mean (standard deviation)
Illiterate 43.06 (20.9) 63.44 (28.2) 39.38 (21.2) 47.38 (20.8) 59.88 (16.3)
Secondary school 44.32 (21.9) 63.25 (21.9) 41.68 (23.1) 48.64 (20.9) 61.21 (14.9)
Graduate/professional 34.64 (19.1) 60.21 (27.2) 34.07 (27.5) 42.00 (24.7) 68.07 (16.07)
Smoking statusb
Never 46.2 66.1 43.2 50.7 52 (16.8)
Ex-smoker 41.1 63.69 37.5 46.05 64.46 (14.7)
Never-smoker 38.9 53.78 42.1 45 65.67 (14.9)
Notes: aSpearman’s rank correlation coefficient; bKruskal-wallis test.
Abbreviations: SGRQ, St George’s Respiratory Questionnaire; wHOQOL-BREF, world Health Organization’s quality of life abbreviated questionnaire.
worsened (Table 8). The CLD severity index correlated 
significantly with both the WHOQOL-BREF (P , 0.05) and 
SGRQ (P , 0.001), suggesting that the greater the severity 
of symptoms, the poorer the QOL. The MRC dyspnea grade 
also showed significant correlation (P , 0.001) with both 
QOL questionnaires. No association was found between 
comorbid illness and QOL (Table 7).
Lung function as measured by FEV1 showed significant 
correlations with both WHOQOL-BREF (P , 0.001) and 
SGRQ (P , 0.001) QOL assessments, indicating that poorer 
lung function was associated with poorer QOL (Table 8). 
Likewise, the FEV1/FVC showed correlation to a lesser 
degree with the WHOQOL-BREF (P , 0.05) and SGRQ 
(P , 0.05). The 6-minute walk, a functional assessment for 
lung disease, showed significant correlation with WHOQOL-
BREF (P = 0.001) and SGRQ (P = 0.005) (Table 8).
Discussion
This study showed that 58 consecutive Indian patients with 
COPD had significantly impaired QOL when measured 
by the generic questionnaire WHOQOL-BREF and the 
disease-specific questionnaire SGRQ. When examining 
specific domains, all showed impairment; however, no 
clear trends were apparent. The social and psychological 
domains on the WHO questionnaire were rated less impaired; 
however, the “impacts” domain (social and psychosocial) 
on the SGRQ appeared more impaired. Jones and Spencer5 
suggested that a four-unit difference in SGRQ score 
between groups of patients indicated a clinically significant 
difference.   Components adversely affecting HRQOL 
include frequency and severity of respiratory symptoms, 
breathlessness causing limitations of activity, poor social 
functions, and psychological disturbances. By concentrating 
investigation and treatment on these selected components, it 
is hoped that patients with COPD might lead fuller and more 
satisfying lives. Antidepressants are helpful for psychological 
disturbances, bronchodilators and narcotics can help dyspnea, 
and pulmonary rehabilitation programs, which are a rarity in 
India, show functional improvement of the 6-minute walk. 
Improvements in peer groups and family support may benefit 
patients by providing more social structure.
Measures of perceived severity of illness (CLD) and 
dyspnea (MRC) likewise showed tight correlation with QOL 
measurements in the study, similar to prior studies.8,9 QOL 
is defined by the WHO as an individual’s perceptions of 
their position in life in the context of the culture and value 
systems in which they live. This study shows that in India, 
COPD patients suffer similar reductions in QOL as do COPD 
patients from other countries, as reported previously.10,11
Lung functions as measured by FEV1 and classified as 
per GOLD criteria showed in this study that the lower the 
FEV1, the lower the patient’s QOL. This association of 
FEV1 and QOL confirms findings from previous studies10,12 
and was anticipated. With worsening lung function, normal 
activity is limited or curtailed. All QOL domains appeared 
Table 5 wHOQOL-BREF results showing number of patients 
with chronic obstructive pulmonary disease by total, domain, and 
mean score
  Good  
(>75)
Fair  
(50–75)
Poor  
(<50)
Mean/ 
standard deviation
Patients, total 14 31 13 62.5 ± 15.6
Patients by domain
Physical 13 18 27 51.6 ± 23.5
Social 25 15 18 62.0 ± 27.3
Psychological 38 13 7 71.8 ± 19.6
Environmental 16 34 8 64.3 ± 14.2
Abbreviation:  wHOQOL-BREF,  world  Health  Organization’s  quality  of  life 
abbreviated questionnaire.
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Table 7 Correlation of clinical disease severity indices (illness duration, CLD, MRC grade for dyspnea) and comorbid illness with 
wHOQOL-BREF and SGRQ
Characteristics Health-related quality of life score
Total score 
WHOQOL-BREF
SGRQ
Symptoms Activity Impacts Total score
r-value P-value r-value P-value r-value P-value r-value P-value r-value P-value
Illness durationa -0.22 0.017* 0.039 0.679 0.07 0.492 0.13 0.69 0.12 0.363
CLDa -0.28 0.003** 0.57 ,0.001*** 0.52 ,0.001*** 0.41 ,0.001*** 0.66 0.001***
MRC grade for dyspneaa -0.51 ,0.001*** 0.37 ,0.001*** 0.60 ,0.001*** 0.55 ,0.001*** 0.7 ,0.001***
Comorbid conditionb -0.14 0.167 -0.15 0.146 -0.03 0.778 -0.07 0.474 -0.08 0.436
Notes: aSpearman’s rank correlation coefficient; bKruskal-wallis test; *P , 0.05; **P , 0.01; ***P , 0.001.
Abbreviations: CLD, Chronic Lung Disease Severity Index; MRC, Medical Research Council; SGRQ, St George’s Respiratory Questionnaire; wHOQOL-BREF, world Health 
Organization’s quality of life abbreviated questionnaire.
Table 8 Correlation of spirometry and 6-minute walk with wHOQOL-BREF and SGRQ
Characteristic Health-related quality of life scores
Total score  
WHOQOL-BREF
SGRQ
Symptoms Activity Impacts Total score
r-value P-value r-value P-value r-value P-value r-value P-value r-value P-value
Lung function (FEV1) 0.35 0.001*** -0.27 0.015* -0.39 0.001** -0.36 0.001** -0.39 ,0.001***
FEV1/FVC% 0.22 0.018* -0.18 0.053 -0.30 0.002** -0.17 0.063 -0.23 0.013*
6-minute walk test 0.36 ,0.001*** -0.06 0.501 -0.28 0.003** -0.27 0.003** -0.26 0.005**
Notes: *P , 0.05; **P , 0.01; ***P , 0.001.
Abbreviations: FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; SGRQ, St George’s Respiratory Questionnaire; wHOQOL-BREF, world Health 
Organization’s quality of life abbreviated questionnaire.
to be similarly impaired by the reduced FEV1. There were 
similar findings when results of the 6-minute walk, an objec-
tive measurement of lung and overall fitness, were analyzed. 
The shorter the distance a patient could walk in 6 minutes, 
the worse perception of his/her QOL.
In previously reported studies, older age, presence of 
comorbid illness, less education, and greater smoking con-
sumption resulted in lower QOL.10,11,13–15 Surprisingly, no 
worsening HRQOL measurement correlated significantly 
with these variables studied in our group of Indians with 
COPD. The cause for this difference in findings in our 
patients compared with patients previously reported is not 
apparent from our data. It may result from small sample 
size, or it may be related to a unique aspect of the Indian 
culture regarding aging and age expectations, appreciation 
for education, or social structure. Ninety-seven percent of 
the patients studied here were married, and the rest were 
widowed/widowers. This reflects the very low overall divorce 
rate in India, and it may be that spousal and societal support 
may contribute in a significant way to improved QOL. This 
is an area that warrants further study.
Limitations of this study include the small sample size of 
58 patients and the fact that 54 of the 58 subjects were male. 
The latter may be explained by the fact that tobacco smoking 
is almost exclusively confined to the male population in 
India. Also, nine of the original group of 73 were excluded 
because they were unable to participate in the 6-minute 
walk, and this may have excluded some patients with more 
severe disease. However, because this study was performed 
in a pulmonary diseases clinic, individuals with more severe 
disease were likely to have been studied. Finally, none of the 
subjects was on long-term oxygen treatment. This is probably 
because oxygen concentrators, which have to be paid for by 
the individuals in the present health care scenario, are not 
easily available and are prohibitively expensive. Thus, COPD 
patients who are older and have generally exhausted their 
resources paying for medical care over the years are unlikely 
to be in a position to afford this treatment.
Conclusion
Indian patients with COPD show significantly reduced 
QOL as measured by standardized questionnaires the 
WHOQOL-BREF and the SGRQ, similar to COPD patients 
in other countries. All domains measured, including 
physical, psychological, social relationships, environmental, 
symptoms, activity, and impacts, were impaired. Severity 
of symptoms, duration of illness, and level of dyspnea also 
influenced the QOL for these individuals. Because COPD is 
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an incurable slowly progressive chronic illness, and because 
only minimal improvement in actual lung function and FEV1 
can occur, concentrating therapy on selected potentially more 
treatable aspects of QOL may result in more effective care.
Further studies should be considered to evaluate the 
impact of social support, family support, and pulmonary 
  rehabilitation programs on the QOL of COPD patients in 
India. Also, in view of the increased prevalence of biomass 
fuel for cooking and heating in rural Indian households, 
studies need to be conducted to study these effects on 
patients, particularly women and their QOL.
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